THE LARGEST PROFITABLE CHAIN OF PSYCHEDELICS CLINICS IN THE U.S. WITH 13 LOCATIONS ACROSS NINE STATES AND 15 MORE IN THE NEXT 18 MONTHS. $9,000,000 + REVENUE RUN RATE & EBITDA POSITIVE
The Delic Umbrella Of Related Businesses Create A Self-Sustaining Ecosystem That Will Drive Clinics Growth
Jackee Stang
CCO/Co-founder
JACKEE STANG is the Founder and CCO of Delic Corp, the first-ever psychedelic wellness
corporation. Jackee is an investor in over twenty consumer cannabis brands and is an early
investor of several key psychedelic startups and pharmaceutical businesses. Stang is the
woman behind High Times Women of Weed, which she started during her tenure as VP of
Programming at High Times Magazine and was the producer behind the award winning
podcast, Bulletproof Radio with Biohacking legend, Dave Asprey.
Jackee aims to re-frame the psychedelic conversation and open the doors of civil discourse to a
mainstream audience.
Delic | Always expanding. In all ways.
Matt Stang
Executive Chairman/Co-founder
Matt Stang was an Owner and Operator of High Times for 17 years prior to its sale to a private
equity fund, and during that time he helped legalize Cannabis in multiple states, launched the
Cannabis Cup in America, and helped build the legal cannabis industry. For almost 20 years he
has met and interacted with all corners within the cannabis community. As one of the most
connected people in the Alternative Drug space he helped found DELIC 2 years ago as the first
psychedelic corporation. His expertise in business includes marketing, branding, business
development and product viability.
Dr. Markus Roggen
CSO
Dr. Markus Roggen is President and Chief Scientific Officer of Delic Labs, a licensed cannabis and psilocybin research laboratory focused on extraction optimization, analytical testing, and process development. Delic Labs is one of a handful of research labs licensed for both cannabis and psilocybin in Canada. Delic Labs was initially founded as Complex Biotech Discovery Ventures by Dr. Roggen and Prof. Dr. Glenn Sammis in 2018, and rebranded after the sale to Delic Corp.
Dr. Roggen received his M/Sci degree from Imperial College, London, UK in 2008. He then pursued his graduate degree in organic chemistry at the Federal Institute of Technology in Zürich (ETHZ), where he received his PhD in 2012. Dr. Roggen was awarded a DAAD postdoctoral fellowship to pursue further training in physical organic chemistry at The Scripps Research Institute in La Jolla in 2013-2014. He then entered the cannabis industry in 2014 and since has held executive positions in analytical and production companies. His research into process optimization and analytical methods has been recognized with a number of awards, ElSohley Award of the ACS, Cannabis Scientist Power List 2020 & 2021, 40 under 40 by Marijuana Venture Magazine among others. Dr. Roggen is also a trusted advisor and mentor to multiple startups, startup accelerators and organizations.